van der Zee AG - Search Results

1

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.

Schröder CP, Wisman GB, de Jong S, van der Graaf WT, Ruiters MH, Mulder NH, de Leij LF, van der Zee AG, de Vries EG. Schröder CP, et al. Among authors: van der graaf wt, van der zee ag. Br J Cancer. 2001 May 18;84(10):1348-53. doi: 10.1054/bjoc.2001.1803. Br J Cancer. 2001. PMID: 11355946 Free PMC article. Clinical Trial.

2

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

van der Zee AG, van Ommen B, Meijer C, Hollema H, van Bladeren PJ, de Vries EG. van der Zee AG, et al. Among authors: van ommen b, van bladeren pj. Br J Cancer. 1992 Nov;66(5):930-6. doi: 10.1038/bjc.1992.388. Br J Cancer. 1992. PMID: 1419639 Free PMC article.

3

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.

van der Zee AG, Hollema H, de Jong S, Boonstra H, Gouw A, Willemse PH, Zijlstra JG, de Vries EG. van der Zee AG, et al. Cancer Res. 1991 Nov 1;51(21):5915-20. Cancer Res. 1991. PMID: 1682037

4

Endodermal sinus tumor of the ovary during pregnancy: a case report.

van der Zee AG, de Bruijn HW, Bouma J, Aalders JG, Oosterhuis JW, de Vries EG. van der Zee AG, et al. Am J Obstet Gynecol. 1991 Feb;164(2):504-6. doi: 10.1016/s0002-9378(11)80009-8. Am J Obstet Gynecol. 1991. PMID: 1704183

5

Excretion of platinum into breast milk.

de Vries EG, van der Zee AG, Uges DR, Sleijfer DT. de Vries EG, et al. Among authors: van der zee ag. Lancet. 1989 Mar 4;1(8636):497. doi: 10.1016/s0140-6736(89)91396-2. Lancet. 1989. PMID: 2563865 No abstract available.

6

Cell biological markers of drug resistance in ovarian carcinoma.

van der Zee AG, Hollema HH, de Bruijn HW, Willemse PH, Boonstra H, Mulder NH, Aalders JG, de Vries EG. van der Zee AG, et al. Gynecol Oncol. 1995 Aug;58(2):165-78. doi: 10.1006/gyno.1995.1205. Gynecol Oncol. 1995. PMID: 7622101 Review.

7

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.

de Jong RS, Willemse PH, Boonstra H, de Vries EG, van der Graaf WT, Sleijfer DT, van der Zee AG, Mulder NH. de Jong RS, et al. Among authors: van der graaf wt, van der zee ag. Eur J Cancer. 1995;31A(5):709-13. doi: 10.1016/0959-8049(94)00516-8. Eur J Cancer. 1995. PMID: 7640042 Clinical Trial.

8

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

van der Zee AG, Hollema H, Suurmeijer AJ, Krans M, Sluiter WJ, Willemse PH, Aalders JG, de Vries EG. van der Zee AG, et al. J Clin Oncol. 1995 Jan;13(1):70-8. doi: 10.1200/JCO.1995.13.1.70. J Clin Oncol. 1995. PMID: 7799045

9

Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.

van der Zee AG, de Cuyper EM, Limburg PC, de Bruijn HW, Hollema H, Bijzet J, Krans M, de Vries EG. van der Zee AG, et al. Cancer. 1995 Feb 15;75(4):1004-9. doi: 10.1002/1097-0142(19950215)75:4<1004::aid-cncr2820750416>3.0.co;2-g. Cancer. 1995. PMID: 7842401

10

Molecular analysis of the topoisomerase II alpha gene and its expression in human ovarian cancer.

van der Zee AG, de Vries EG, Hollema H, Kaye SB, Brown R, Keith WN. van der Zee AG, et al. Ann Oncol. 1994 Jan;5(1):75-81. doi: 10.1093/oxfordjournals.annonc.a058700. Ann Oncol. 1994. PMID: 8172796 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page